Device Trial Radar · NCT05079906
Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® Catheter
Last checked: Nov 20, 2026Latest source record: Oct 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
May 2022
Primary completion
Jun 2024
Study completion Jun 2024
Sponsor
- Lead sponsor
- Acist Medical SystemsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 15, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is intended to help establish standard procedures for use of FFR in the peripheral arterial system and to evaluate the correlation of post-procedural FFR values and clinical outcomes in Superficial Femoral artery (SFA) interventions in subjects ages 18 to 79 with PAD.
Conditions
- Peripheral Arterial Disease
- Superficial Femoral Artery Stenosis
Interventions
Fractional Flow Reserve (FFR)Device
Fractional Flow Reserve (FFR) for all enrolled subjects. All interventional procedures, including FFR and HD IVUS, will be conducted in accordance with current approved User Guides and Instructions for Use.
High Definition Intravascular Ultrasound (HD-IVUS)Device
High Definition Intravascular Ultrasound (HD-IVUS) in addition to FFR for last 50 enrolled subjects. All interventional procedures, including FFR and HD IVUS, will be conducted in accordance with current approved User Guides and Instructions for Use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-PVI FFRTime frame: 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.